GILEAD SCIENCES DL-,001/ US3755581036 /
26/04/2024 21:31:58 | Diferencia +0.740 | Volumen | Bid22:00:02 | Ask22:00:02 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
61.370EUR | +1.22% | 6,299 Volumen de negocios: 385,523.050 |
61.100Volumen de oferta: 110 | 61.240Tamaño/ Volumen/ Formato de Ask: 110 | 76.23 mil millonesEUR | - | - |
Newsfile Corp
3:20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocu...
GlobeNewswire
2:40
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to ...
GlobeNewswire
2:17
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with L...
Newsfile Corp
1:11
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Se...
Newsfile Corp
28/04
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Befor...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página